期刊文献+

卵巢癌药敏试验的微量法研究 被引量:1

Application of a Micromethod in Ovarian Cancer Chemosensitivity Testing in vitro
暂未订购
导出
摘要 目的 探讨微量检测 ATP在卵巢癌药敏试验中应用的可行性。方法 对 35例新鲜卵巢癌组织标本进行药敏试验 ,应用 Victor 2多功能检测仪微量检测 ATP值。结果  1Victor 2多功能检测仪微量检测 ATP标准品与发光值的关系 ,在 ATP浓度为 10 - 9~ 10 - 5m ol/ml时 ,显示极好的线性关系 ,直线方程为 Y =0 .892 X +10 .2 5 7,相关系数 r=0 .998(P<0 .0 1)。 2微量检测 ATP的变异系数平均为 7.3%。 3微量检测 ATP进行药敏试验 ,敏感性 92 .0 % ,特异性 70 .0 % ,预测准确率为 87.1%。结论 应用 Victor 2多功能检测仪微量检测 ATP进行药敏试验 ,方法稳定 ,实验成本降低 ,更为简便、快速 ,误差小 。 Objective To assess the efficacy of microdetermination in the ATP bioluminescence assay (ATP CVA) of ovarian cancer chemosensitivity testing in vitro . Methods A micromethod ATP CVA was employed in determining the chemosensitivity of 35 specimens of fresh ovarian cancer cells using Victor 2 Multilabel Counter. Results ① By use of Victor2 Mutilabel Counter to determine ATP, in a range of 10 -9 10 -5 mol/ml, a linear relationship was remarkable between the log ATP and the log luminescence. The equation was Y= 0.892X+10 257, the correlation coefficient r was 0.998, P <0.01. ② The coefficient of variation obtained from ATP CVA was 7.3%. ③ The sensitivity of the test was 92.0%, the specificity 70.0%, and the total predictive accuracy of ATP CVA 87.1%. Conclusion With the use of Victor 2 Mutilabel Counter, ATP CVA is fast, eost effective, and easy to perform with only small error.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2003年第2期298-299,312,共3页 Journal of Sichuan University(Medical Sciences)
关键词 药物敏感性试验 微量法 卵巢癌 ATP法 Chemosensitivity test Micromethod Ovarian cancer ATP CVA assay
  • 相关文献

参考文献2

二级参考文献6

共引文献10

同被引文献9

  • 1Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat, 1995, 36(2):169.
  • 2Kitange G, Shibats S, Tokunags Y, et al. Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. Laboratary Investigation,1999;79(4) :407.
  • 3Gualandris A, Rusnati M, Balleri M, et al. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.Cell Growth Differ, 1996; 7(2):147.
  • 4Ogasawara S, Yano H, Iemura A,et al. Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines.Hepatology, 1996;24(1):198.
  • 5Nemati MN, Stan AC, Putz KM, et al. Inhibition of angiogenesis and growth of malignant gliomas in the athymic nude rat model: immunotherapy against "basic flbroblast growth factor". Zentralbl Neurochir, 1996, 57(1):12.
  • 6Amelia C, Petra W, Maria-Antonietta I, et al. Fibroblast growth factors are required for efficient tumor angiogenesis.Cancer Res, 2000; 60(5) : 7163.
  • 7Lavrovsky VA, Chagin AS. Subkhankulova TN.Internalization of growth factor-receptor complexes under the influence of antibodies initiates cell apoptosis in vitro. Eur J Cell Biol, 1999; 78(3):194.
  • 8Keiji I, Paul P, Christopher G,et al. Gene therapy of human bladder cancer with Adenovirus-mediated antisense basic fibroblast growth factor. Clin Cancer Res, 2000; 6(1):4422.
  • 9林卫,彭芝兰.碱性成纤维细胞生长因子在卵巢上皮性肿瘤中的表达及意义[J].中国修复重建外科杂志,1999,13(5):299-304. 被引量:26

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部